MIT Sues Dharmacon Over Payments for RNA Interference-Related IP License | GenomeWeb

The Massachusetts Institute of Technology is suing Dharmacon for failing to pay sufficient royalties on the sale of its RNAi products, according to court documents obtained by RNAi News.

According to MIT’s lawsuit filed in the US District Court for the District of Massachusetts, the research institute in December 2001 granted Dharmacon co-exclusive rights to use its siRNA technology for internal research or to sell research reagents based on the technology for educational and research purposes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.